Please login to the form below
Alzheimer's drug
This page shows the latest Alzheimer's drug news and features for those working in and with pharma, biotech and healthcare.
TauRx shares phase 3 trial data for Alzheimer's drug
The trial assessed TauRx’s lead investigative oral drug, HMTM, which has been tested in 598 people diagnosed with Alzheimer’s. ... He added: “Today with limited treatments for Alzheimer’s, the standard of care does not impact the underlying
Latest news
-
Biogen retracts EMA application for Alzheimer's drug Aduhelm
Following regulatory blocks and rejections late last year, Biogen has decided to withdraw its application for its Alzheimer's drug Aduhelm (aducanumab) in Europe. ... working towards the goal of bringing new treatment options to people living with
-
Study provides new insights into Alzheimer's disease
The study used the genomes of 100, 000 people with Alzheimer’s and 600, 000 healthy individuals. ... The findings also validated the importance of amyloid beta and tau proteins, which have been under scrutiny during the drug discovery efforts in
-
AbbVie acquires Syndesi Therapeutics in $1bn deal
The deal will allow AbbVie to access Syndesi’s research into Alzheimer's disease. ... AbbVie has been heavily involved in various Alzheimer’s projects, including an amyloid-beta drug the company believes could work against the degenerative disease.
-
Biogen’s Alzheimer’s treatment Aduhelm limited to clinical trial participants in the US
monoclonal antibodies for Alzheimer's disease – will be limited exclusively to participants in qualified clinical trials. ... Following a thorough analysis, CMS discovered that although Aduhelm had the potential to help patients with Alzheimer's disease
-
First trial of a vaccine against Alzheimer’s launches
migrate to the brain and trigger the clearance of beta amyloid plaque, one of the hallmarks of Alzheimer’s disease. ... However, there has been renewed interest across the industry in recent years, culminating in the approval of the first treatment for
More from news
Approximately 7 fully matching, plus 147 partially matching documents found.
Latest Intelligence
-
Alzheimer’s disease: the search for a cure
We are expecting to see the outcomes of an FDA priority review of the potential Alzheimer’s drug, aducanumab, this year. ... Over the past two decades, Alzheimer’s drug discovery has largely focused on targeting the hallmark amyloid protein.
-
Alzheimer’s: the search for a cure
Tau is emerging as a target for drug development in Alzheimer’s, as well as other disorders like frontotemporal dementia. ... Organisations including the Alzheimer’s Drug Discovery Foundation (ADDF) think combinations of molecules with these
-
Detecting Alzheimer’s ahead of a cure
Biogen and Eisai also pulled the plug on their Alzheimer’s drug aducanumab, after advice from an independent data monitoring committee forced them to abandon the phase 3 Abeta-targeting candidate. ... It was just another in a string of late-stage
-
Where next in Alzheimer’s disease R&D?
This evidence has spurred research and led. organisations including the Alzheimer’s Drug Discovery Foundation and AC Immune to conclude that combination therapies may be needed to tackle such a complex ... Read more: Brain power: fresh approaches to
-
Brain power: fresh approaches to Alzheimer’s drug discovery
Two further candidates, AL003 for Alzheimer’s disease and AL004 for multiple degenerative disorders, are also set to enter clinical trials this year. ... Diseases include Alzheimer’s, dementia with Lewy bodies, frontotemporal dementia, as well as
More from intelligence
Approximately 0 fully matching, plus 8 partially matching documents found.
Latest appointments
-
Bone Therapeutics looks to Pfizer for clinical head
He has spent a majority of his career at Pfizer, where he held a number of senior roles including medical director for Pfizer Switzerland, European team leader for the Alzheimer's ... disease drug Aricept and medical team leader for its anti-inflammatory
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Vice President, Medical Communications, UK, six figure package
-
Six figure salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- Bristol Myers Squibb announces positive trial results for treatment of MS
- My journey advancing the science in pulmonary hypertension
- A new era for UK-Japanese scientific research relations
- Enanta takes legal action against Pfizer over Paxlovid patent infringement
- Innovative Health Initiative launches first two calls for proposals to tackle ‘biggest’ health research challenges
- Pfizer and BioNTech share positive results for Omicron-adapted COVID-19 vaccine
- NICE issues final draft recommending Novartis’ Scemblix to treat chronic myeloid leukaemia
- Alzheimer's Research UK supports government plans for clinical research
- GSK announces The HealthTree Foundation’s multiple myeloma programme as first ‘Think Tank’ challenge winner
- NRG Therapeutics partners with Domainex to develop neurodegenerative disease treatment
- Innovative Trials opens first US office
- Scanning for Health Indicators and Risks Through Your Smartphone
- Realising the potential of omnichannel in medical communications
- College of Medicine launches Beyond Pills campaign to tackle overprescribing in UK health system
- AI is transforming pharma R&D – now it can transform pharma marketing
- J&J’s Darzalex shows ‘significant’ survival benefit in newly diagnosed multiple myeloma
- Six UK universities receive grant for research into motor neurone disease
- My journey advancing the science in pulmonary hypertension
PMHub
Life Healthcare Communications
Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...
Latest intelligence
- Our Top 5 Pharma Picks From Cannes Lions
- Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
- The Evolving Role of the Sales Rep
- The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
- Measure your omnichannel maturity with our new tool
- Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....
